Effect of chemotherapy delays and dose reductions on progression free and overall survival in the treatment of epithelial ovarian cancer

BACKGROUND: Hematologic, gastrointestinal, and neurologic complications are common side effects of the platinum/taxane based chemotherapy used in the primary treatment of epithelial ovarian cancer (EOC). While these are well-documented side effects, the effect of the resultant chemotherapy delay or...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Nagel, CI, Backes, FJ, Donner, J, Bussewitz, E, Hade, EM, Cohn, DE, Eisenhauer, EL, O’Malley, DM, Fowler, JM, Copeland, LJ, Salani, R
Médium: Artigo
Jazyk:Inglês
Vydáno: 2011
Témata:
Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4035808/
https://ncbi.nlm.nih.gov/pubmed/22055764
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ygyno.2011.10.003
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky